Fatal Intestinal Amoebiasis M
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
STD History and Physical Assessment Date of Service: Patient Demographics Last Name First Name Middle Initial Pref
STD History and Physical Assessment Date of Service: Patient Demographics Last Name First Name Middle Initial Pref. name/AKA/pronoun Date of Birth Sex (at birth) Gender (all that apply Race Ethnicity Female Female Transgender Pref. Pronoun: American Indian/Alaskan Native Asian African American Hispanic Male Male Self Define: Hawaiian/Pacific Islander White Other Non-Hispanic Street Address City State Zip County Home Telephone Cell Phone Vitals: Temp: Pulse: RR: BP: Referral Source: Reason for Visit Male Symptom History Previous STD Yes No Reason Yes No (check appropriate boxes) Chlamydia Gonorrhea Patient has genital lesions, genital discharge, or other Hep. C Herpes symptoms suggestive of a sexually transmitted disease Clear, milky or mucoid urethral discharge HIV HPV Patient has partner with genital lesions, genital discharge, or Dysuria , urethral “itch”, frequency, urgency PID Syphilis other symptoms suggestive of a sexually transmitted disease Sore throat and/or hoarseness Other: Patient has partner treated for a sexually transmitted disease Scrotal pain, swelling, redness Comments: Patient referred by local or state DIS. Review labs and refer to Rectal discharge, pain during defecation appropriate STD treatment SDO Rash Medications Patient requesting STD testing – denies reasons listed above Asymmetric, painful, swollen joints Antibiotics last 4 weeks? Yes No If patient seen within past 30 days: Name Purpose Patient has persistent symptoms? Yes No If Yes, was partner treated? Yes No Unknown Female Symptom History Chronic medications -
An Unusual Case of Amoebic Liver Abscess Presenting with Hepatic Encephalopathy: a Case Report
Case Report An Unusual Case of Amoebic Liver Abscess Presenting with Hepatic Encephalopathy: A Case Report Anil Kumar SARDA, Rakesh MITTAL Submitted: 16 Sep 2010 Department of Surgery, Maulana Azad Medical College and Lok Nayak Accepted: 3 Jan 2011 Hospital, New Delhi 110 002, India Abstract Amoebic liver abscess (ALA) with jaundice and encephalopathy is a rare occurrence and has been recognised and studied more frequently in recent years. We present a case of massive ALA presenting with jaundice, hepatic encephalopathy, and septicaemia that was treated successfully with percutaneous drainage of the abscess, right-sided chest tube insertion, and anti-amoebic therapy. Keywords: amoebiasis, hepatic encephalopathy, hepatology, jaundice, liver abscess Introduction On chest examination, there was bilateral equal air entry. Upon investigation, haemoglobin was Amoebic liver abscess (ALA) is the most 11 g/dL, with a total leukocyte count of frequent extra-intestinal manifestation of 13 000 cells/mm3 (normal range is 4000– Entamoeba histolytica infection. It has been 11 000 cells/mm3). Liver function tests revealed reported that jaundice is uncommon and mild total serum bilirubin of 20 mg/dL, with direct in liver abscess, and some even consider the bilirubin of 15 mg/dL, serum glutamic-oxaloacetic presence of jaundice as a feature against the transaminase (SGOT) of 324 IU/L (normal level diagnosis of hepatic amoebiasis (1). The cause of is less than 40 IU/L), serum glutamic–pyruvic jaundice in a case of ALA has been hypothesised transaminase (SGPT) of 340 IU/L (normal level to result from either hepatocellular dysfunction or is less than 40 IU/L), and alkaline phosphatase intrahepatic biliary obstruction (2). -
Amebiasis Annual Report 2017
Amebiasis Annual Report 2017 Amebiasis Amebiasis is no longer a reportable disease in Louisiana. Outbreaks, however, should still be reported. Amebiasis (amoebiasis) is a parasitic infection caused by Entamoeba histolytica or Entamoeba dispar. The parasite is transmitted by the fecal-oral route, either through direct contact with feces or through the consumption of contaminated food or water. Between 80% and 90% of infected individuals develop no symptoms. For symptomatic cases, the incubation period between infection and illness can range from days to weeks. The symptoms are typically gastrointestinal issues, such as diarrhea or stomach pains. It is also possible for the parasite to spread to the liver and cause abscesses. Entamoeba histolytica can be found world-wide, but is more prevalent in tropical regions with poor sanitary conditions. In some areas with extremely adverse conditions, the prevalence can be as high as 50% in the population. There are no recent data on prevalence of amebiasis in the U.S. however, prevalence is estimated to be between 1% and 4% of the population. High risk groups are refugees, recent immigrants, travelers (particularly those who have spent long periods of time in an endemic area), institutionalized people (particularly developmentally or mentally-impaired people), and men who have sex with men. The number of cases reported within Louisiana is usually low. There are typically less than ten cases per year with a few exceptions (Figure 1). Figure 1: Amebiasis cases - Louisiana, 1970-2017 40 35 30 25 20 15 Number of Cases Number 10 5 0 70 72 74 76 78 80 82 84 86 88 90 92 94 96 98 00 02 04 06 08 10 12 14 16 Year Louisiana Office of Public Health – Infectious Disease Epidemiology Section Page 1 of 4 Amebiasis Annual Report 2017 Hospitalization Hospitalization surveillance is based on Louisiana Hospital Inpatient Discharge Data (LaHIDD). -
Surveillance Study of Acute Gastroenteritis Etiologies in Hospitalized Children in South Lebanon (SAGE Study)
pISSN: 2234-8646 eISSN: 2234-8840 https://doi.org/10.5223/pghn.2018.21.3.176 Pediatr Gastroenterol Hepatol Nutr 2018 July 21(3):176-183 Original Article PGHN Surveillance Study of Acute Gastroenteritis Etiologies in Hospitalized Children in South Lebanon (SAGE study) Ghassan Ghssein, Ali Salami, Lamis Salloum, Pia Chedid*, Wissam H Joumaa, and Hadi Fakih† Rammal Hassan Rammal Research Laboratory, Physio-toxicity (PhyTox) Research Group, Lebanese University, Faculty of Sciences (V), Nabatieh, *Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Balamand, †Department of Pediatrics, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon Purpose: Acute gastroenteritis (AGE) is a major cause of morbidity and remains a major cause of hospitalization. Following the Syrian refugee crisis and insufficient clean water in the region, this study reviews the etiological and epidemiological data in Lebanon. Methods: We prospectively analyzed demographic, clinical and routine laboratory data of 198 children from the age of 1 month to 10 years old who were admitted with the diagnosis of AGE to a private tertiary care hospital located in the district of Nabatieh in south Lebanon. Results: Males had a higher incidence of AGE (57.1%). Pathogens were detected in 57.6% (n=114) of admitted pa- tients, among them single pathogens were found in 51.0% (n=101) of cases that consisted of: Entamoeba histolytica 26.3% (n=52), rotavirus 18.7% (n=37), adenovirus 6.1% (n=12) and mixed co-pathogens found in 6.6% (n=13). Breast-fed children were significantly less prone to rotavirus (p=0.041). Moreover, children who had received the rota- virus vaccine were significantly less prone to rotavirus (p=0.032). -
Amoebic Colitis Presenting As Subacute Intestinal Obstruction with Perforation
International Journal of TROPICAL DISEASE & Health 41(16): 58-62, 2020; Article no.IJTDH.61831 ISSN: 2278–1005, NLM ID: 101632866 Amoebic Colitis Presenting as Subacute Intestinal Obstruction with Perforation Renuka Verma1, Archana Budhwar1*, Priyanka Rawat1, Niti Dalal1, Anjali Bishlay1 and Sunita Singh1 1Pt. B. D. Sharma Post Graduate Institute of Medical Sciences, Rohtak-124001, Haryana, India. Authors’ contributions This work was carried out in collaboration among all authors. Authors RV and SS designed the study, reviewed the manuscript and edited it. Author Archana Budhwar wrote the protocol and wrote the first draft of the manuscript. Author PR managed the literature searches. Authors ND and Anjali Bishlay managed the analyses of the study. All authors read and approved the final manuscript. Article Information DOI: 10.9734/IJTDH/2020/v41i1630367 Editor(s): (1) Dr. Giuseppe Murdaca, University of Genoa, Italy. Reviewers: (1) Ammar M. Al-Aalim, Mosul University, Iraq. (2) Tarunbir Singh, Guru Angad Dev Veterinary & Animal Sciences University, Ludhiana. Complete Peer review History: http://www.sdiarticle4.com/review-history/61831 Received 10 August 2020 Case Study Accepted 16 October 2020 Published 12 November 2020 ABSTRACT Infestation with Entamoeba histolytica is worldwide, especially in developing areas. Presented case study included amoebic colitis in a 45 years old man complaining of abdominal distension and non- passage of stools since three days. Abdominal region was diffusely distended and tender in right iliac fossa. Plain abdominal radiography revealed prominent gut loops and minimal intergut free fluid. At laparotomy, malrotation of gut was present. Histopathological examination of intestinal samples confirmed final diagnosis of amoebic colitis post-operatively. -
Improved Genomic Assembly and Genomic Analyses of Entamoeba Histolytica
Improved genomic assembly and genomic analyses of Entamoeba histolytica Thesis submitted in accordance with the requirements of the University of Liverpool for the degree of Doctor in Philosophy by Amber Leckenby September 2018 Acknowledgements There are many people without whom this thesis would not have been possible. The list is long and I am truly grateful to each and every one. Firstly I have to thank my supervisors Gareth, Christiane, Neil and Steve for the continuous support throughout my PhD. Particularly, I am grateful to Gareth and Christiane, for their patience, motivation and immense knowledge that helped me through the entirety of the proJect from the initial research to the writing of this thesis. I cannot have imagined having better mentors and role models. I also have to thank the staff at the CGR for their role in the sequencing aspects of this thesis. My further thanks extend to the CGR bioinformatics team, most notably Richard, Matthew, Sam and Luca, for not only tolerating the number of bioinformatics questions I have asked them, but also providing great friendship and warmth in the office. I must also give a special mention to Graham Clark at the London School of Hygiene and Tropical Medicine for sending cultures of Entamoeba and providing general advice, especially around the tRNA arrays. I would also like to thank David Starns, for his efforts troubleshooting the Companion pipeline and to Laura Gardiner for providing advice around all things methylation. My gratitude goes to the members of the many offices I have moved around during my PhD, many of which have become close friends who have got me through many bioinformatics conundrums, lab meltdowns and (some equally challenging) gym sessions. -
Sexually Transmitted Diseases Treatment Guidelines, 2015
Morbidity and Mortality Weekly Report Recommendations and Reports / Vol. 64 / No. 3 June 5, 2015 Sexually Transmitted Diseases Treatment Guidelines, 2015 U.S. Department of Health and Human Services Centers for Disease Control and Prevention Recommendations and Reports CONTENTS CONTENTS (Continued) Introduction ............................................................................................................1 Gonococcal Infections ...................................................................................... 60 Methods ....................................................................................................................1 Diseases Characterized by Vaginal Discharge .......................................... 69 Clinical Prevention Guidance ............................................................................2 Bacterial Vaginosis .......................................................................................... 69 Special Populations ..............................................................................................9 Trichomoniasis ................................................................................................. 72 Emerging Issues .................................................................................................. 17 Vulvovaginal Candidiasis ............................................................................. 75 Hepatitis C ......................................................................................................... 17 Pelvic Inflammatory -
ESMO Colorectal Cancer Guide for Patients English
Colorectal Cancer What is colorectal cancer? Let us explain it to you. www.anticancerfund.org www.esmo.org ESMO/ACF Patient Guide Series based on the ESMO Clinical Practice Guidelines COLORECTAL CANCER: A GUIDE FOR PATIENTS PATIENT INFORMATION BASED ON ESMO CLINICAL PRACTICE GUIDELINES This guide for patients has been prepared by the Anticancer Fund as a service to patients, to help patients and their relatives better understand the nature of colorectal cancer and appreciate the best treatment choices available according to the subtype of colorectal cancer. We recommend that patients ask their doctors about what tests or types of treatments are needed for their type and stage of disease. The medical information described in this document is based on the clinical practice guidelines of the European Society for Medical Oncology (ESMO) for the management of colorectal cancer. This guide for patients has been produced in collaboration with ESMO and is disseminated with the permission of ESMO. It has been written by a medical doctor and reviewed by two oncologists from ESMO including the leading author of the clinical practice guidelines for professionals. It has also been reviewed by patient representatives from ESMO’s Cancer Patient Working Group. More information about the Anticancer Fund: www.anticancerfund.org More information about the European Society for Medical Oncology: www.esmo.org For words marked with an asterisk, a definition is provided at the end of the document. Colorectal Cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 1 This document is provided by the Anticancer Fund with the permission of ESMO. -
Clinical Guidelines for Diagnosis and Treatment of Common Conditions in Kenya
Clinical Guidelines for Diagnosis and Treatment of Common Conditions in Kenya Table of Contents Clinical Guidelines for Diagnosis and Treatment of Common Conditions in Kenya..................................1 FOREWORD..........................................................................................................................................3 PREFACE...............................................................................................................................................4 ACKNOWLEDGEMENTS.......................................................................................................................5 ABBREVIATIONS...................................................................................................................................5 1. ACUTE INJURIES AND TRAUMA & SELECTED EMERGENCIES..................................................7 1.1. Anaphylaxis & Cardiac Arrest...................................................................................................7 1.2. Abdominal Trauma....................................................................................................................8 1.3. Bites & Rabies.........................................................................................................................10 1.4. Burns.......................................................................................................................................13 1.5. Disaster Plan...........................................................................................................................16 -
Granulomatous Meningoencephalitis Balamuthia Mandrillaris in Peru: Infection of the Skin and Central Nervous System
SMGr up Granulomatous Meningoencephalitis Balamuthia mandrillaris in Peru: Infection of the Skin and Central Nervous System A. Martín Cabello-Vílchez MSc, PhD* Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical “Alexander von Humboldt” *Corresponding author: Instituto de Medicina Tropical “Alexander von Humboldt”, Av. Honorio Delgado Nº430, San A. Martín Cabello-Vílchez, Universidad Peruana Cayetano Heredia, MartínPublished de Porras, Date: Lima-Perú, Tel: +511 989767619, Email: [email protected] February 16, 2017 ABSTRACT Balamuthia mandrillaris is an emerging cause of sub acute granulomatous amebic encephalitis (GAE) or Balamuthia mandrillaris amoebic infection (BMAI). It is an emerging pathogen causing skin lesions as well as CNS involvement with a fatal outcome if untreated. The infection has been described more commonly in inmunocompetent individuals, mostly males, many children. All continents have reported the disease, although a majority of cases are seen in North and South America, especially Peru. Balamuthia mandrillaris is a free living amoeba that can be isolated from soil. In published reported cases from North America, most patients will debut with neurological symptoms, where as in countries like Peru, a skin lesion will precede neurological symptoms. The classical cutaneous lesionis a plaque, mostly located on face, knee or other body parts. Diagnosis requires a specialized laboratory and clinical experience. This Amoebic encephalitis may be erroneously interpreted as a cerebral neoplasm, causing delay in the management of the infection. Thediagnosis of this infection has proven to be difficult and is usually made post-mortem but in Peru many cases were pre-morten. Despite case fatality rates as high as > 98%, some experimental therapies have shown protozoal therapy with macrolides and phenothiazines. -
Rectal Prolapse: an Overview of Clinical Features, Diagnosis, and Patient-Specific Management Strategies
J Gastrointest Surg (2014) 18:1059–1069 DOI 10.1007/s11605-013-2427-7 EVIDENCE-BASED CURRENT SURGICAL PRACTICE Rectal Prolapse: An Overview of Clinical Features, Diagnosis, and Patient-Specific Management Strategies Liliana Bordeianou & Caitlin W. Hicks & Andreas M. Kaiser & Karim Alavi & Ranjan Sudan & Paul E. Wise Received: 11 November 2013 /Accepted: 27 November 2013 /Published online: 19 December 2013 # 2013 The Society for Surgery of the Alimentary Tract Abstract Rectal prolapse can present in a variety of forms and is associated with a range of symptoms including pain, incomplete evacuation, bloody and/or mucous rectal discharge, and fecal incontinence or constipation. Complete external rectal prolapse is characterized by a circumferential, full-thickness protrusion of the rectum through the anus, which may be intermittent or may be incarcerated and poses a risk of strangulation. There are multiple surgical options to treat rectal prolapse, and thus care should be taken to understand each patient’s symptoms, bowel habits, anatomy, and pre-operative expectations. Preoperative workup includes physical exam, colonoscopy, anoscopy, and, in some patients, anal manometry and defecography. With this information, a tailored surgical approach (abdominal versus perineal, minimally invasive versus open) and technique (posterior versus ventral rectopexy +/− sigmoidectomy, for example) can then be chosen. We propose an algorithm based on available outcomes data in the literature, an understanding of anorectal physiology, and expert opinion that can serve as a guide to determining the rectal prolapse operation that will achieve the best possible postoperative outcomes for individual patients. Keywords Rectal prolapse . Management . Surgery . ’ . Liliana Bordeianou and Caitlin W. Hicks are co-first authors. -
3-Treatment of Dysentery and Amoebiasis .Pdf
Treatment of dysentery and amoebiasis Objectives: 1. To understand different causes of dysentery. 2. To describe different classes of drugs used in treatment of both bacillary dysentery and amebic dysentery. 3. To be able to describe actions, side effects of drugs for treating bacillary dysentery. 4. To understand the pharmacokinetics, actions, clinical applications and side effects of antiamebic drugs. 5. to be able to differentiate between types of antiamebic drugs; luminal amebicides, and tissue amebicide. Editing File Color index: Important Note Extra Mind Maps Mnemonics Metronidazole اﻟﻤﯿﺘﻮ ﯾﻤﺸﻲ ﻻﻣﺎﻛﻦ ﺑﻌﯿﺪه ﻓﯿﺼﯿﺮ ﻧﺴﺘﺨﺪم ھﺬا اﻟﺪرق ﻓﻲ( Metro → systemic amoebicides( trophozoites - ﻧﺪى ﻗﺮﯾﯿﯿﺐ ﻣﻦ DNA ﻓﮭﻮ ﯾﺴﻮي اﻧﮭﺒﺖ ﻟﺪي ان اي رﯾﺒﻠﯿﻜﯿﺸﻦ → Nida - ﺟﺎﯾﮫ اﺣﺎول اﺻﯿﺮ طﺒﯿﺒﺔ اﺳﻨﺎن ﺑﺲ ﻗﺎﻟﻮا ﻟﻲ ﺑﻮو ﯾﺎ ﻛﺬاﺑﮫ !Clinical uses : Gia tri pu pseudo - .giardiasis → (ﺟﺎﯾﮫ) Gia - .trichomoniasis → (اﺣﺎول) Tri - طﺒﯿﺒﺔ أﺳﻨﺎن → ﯾﺴﺘﺨﺪم ﻓﻲ اﻟﺪﯾﻨﺘﺎل ﺑﺮاﻛﺘﺲ- .peptic ulcer → (ﺑﻮ) Pu - pseudomembranous colitis → (ﻛﺬاﺑﮫ)Pseudo - ﻧﺪى طﺒﯿﺒﺔ اﺳﻨﺎن طﯿﺐ ؟ : ADRs- ﺣﻄﺖ اﻟﺴﯿﻜﺸﻦ وﺻﺎر اﻟﻔﻢ ﺟﺎااف (dry mouth) ﺛﻢ ﺣﻄﺖ اﻟﺒﻨﺞ وﺻﺎر طﻌﻤﮫ ﻣﻮ ﺣﻠﻮ (metallic taste ) ﻋﺎد ﻧﺪى ﻛﺜﺮت ﺑﻨﺞ وﻛﺎن ﯾﺤﺒﮫ اﻟﻔﻨﻘﻞ ﻟﯿﻦ ﺳﻮى ﻟﻲoral thrush وﺑﻌﺪ ﻣﻦ ﻛﺜﺮة اﻟﺒﻨﺞ داﺧﺖ اﻟﺒﯿﺸﻨﺖ وﺻﺎر ﻋﻨﺪھﺎ neurotoxicological effect وﻟﻼﺳﻒ اﻟﺒﯿﺸﺖ ﺑﻠﻌﺖ ﻧﺺ اﻟﺒﻨﺞ وطﻠﻊ ﻣﻊ اﻟﯿﻮرن (dysuria ) وﻻﻧﮭﺎ اﺧﺬت ﻛﺤﻮل ﻗﺒﻞ ﺗﺮوح ﻟﻠﺪﻛﺘﻮره ﻧﺪى ﺻﺎر ﻓﯿﮫ ﺗﻌﺎرض ﻣﻊ اﻟﺒﻨﺞ اﻟﻠﻲ ﺑﻠﻌﺘﮫ (disulfiram like effect) . Emetine وﺣﺪه ﻣﻮﺻﯿﮫ اﺧﺘﮭﺎ ﺗﺠﯿﺐ ﻟﮭﺎ ﺑﺮوﺗﯿﻦ ﺑﺎر ، طﻮﻟﺖ اﺧﺘﮭﺎ ودﻗﺖ ﻋﻠﯿﮭﺎ ﻗﺎﻟﺖ اﻣﺘﺎ ﺗﺠﯿﻦ طﻮﻟﺘﻲ ؟ (emetine) ﻗﺎﻟﺖ اﺧﺘﮭﺎ ﻣﺎرااح اﺟﻲ وﻣﺎﻓﯿﮫ ﺑﺮوﺗﯿﻦ ﺑﺎر ، ﻓﺎﯾﺸﯿﺴﻮي